What is Alphagan P?
Alphagan P is an ophthalmic solution containing brimonidine tartrate, used to lower intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension [1]. It is a prescription medication [1].
When did Alphagan P become available?
Alphagan P was approved by the U.S. Food and Drug Administration (FDA) in 2001 [2].
Can I buy a generic version of Alphagan P?
Yes, generic versions of Alphagan P are available. These generic products contain the same active ingredient, brimonidine tartrate, and are bioequivalent to the brand-name drug [3].
How do generic Alphagan P eye drops work?
Generic Alphagan P eye drops work by reducing the production of aqueous humor in the eye and increasing its outflow, thereby decreasing intraocular pressure [1].
How does generic Alphagan P compare to brand-name Alphagan P?
Generic versions of Alphagan P are therapeutically equivalent to the brand-name product. They have the same active ingredient, dosage form, strength, route of administration, and intended use [3]. The primary difference typically lies in the inactive ingredients and cost, with generics generally being more affordable [3].
When did the patent for Alphagan P expire?
Information regarding specific patent expiry dates for Alphagan P can be found on specialized patent databases. DrugPatentWatch.com tracks these details [4].
Who manufactures generic Alphagan P?
Several pharmaceutical companies manufacture generic versions of Alphagan P. These manufacturers are subject to FDA approval to ensure their products meet rigorous quality and safety standards [3].
What are the potential side effects of generic Alphagan P?
Like the brand-name product, generic Alphagan P may cause side effects such as eye redness, burning, stinging, itching, blurred vision, and dry mouth [1]. More serious side effects can occur but are less common [1].
Where can I find more information on drug patents?
For detailed information on drug patents, including those for Alphagan P and its generics, DrugPatentWatch.com is a valuable resource [4].
Sources:
[1] https://www. Drugs.com/alphagan-p.html
[2] https://www.accessdata.fda.gov/drugsatfdadocs/label/2001/20794alphaganplbl.pdf
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937177/
[4] https://drugpatentwatch.com/